A Jefferies & Co. analyst kept a “Buy” rating on Allergan Inc. Tuesday, saying the stock should rise as the company finds new medical uses for its Botox anti-wrinkle product.
More: continued here
| Home | Photos | Surgery Types | Cosmetic Surgeons | Surgery Prices | Surgery Risks | Plastic Surgery News |
Ahead of the Bell: Allergan (AP via Yahoo! Finance)
Related News
Leave a Reply
News by Category
- Arm Lift (592)
- Botox (489)
- Breast Augmentation (268)
- Breast Lift (363)
- Brow Lift (113)
- Butt Lift (263)
- Celebrity Plastic Surgery (152)
- Chin Augmentation (9)
- Collagen (510)
- Ear Surgery (492)
- Eyelid Lift (38)
- Face Lift (212)
- Forehead Lift (128)
- Hair Replacement (490)
- Laser Skin Resurfacing (83)
- LASIK (1455)
- Lip Augmentation (20)
- Liposuction (498)
- Nose Job (913)
- Plastic Surgery (89)
- Thigh Lift (210)
- Tummy Tuck (1114)
- Weight Loss Surgery (2001)